|Articles|July 23, 2013
Focusing on Quality for Parenteral Drug Manufacturing
Susan Schniepp, vice-president of quality and regulatory affairs at Allergy Laboratories and co-chair of the program planning committee for the 2013 PDA/FDA Joint Regulatory Conference, discusses quality systems and related considerations in parenteral drug manufacturing.
Advertisement
Susan Schniepp, vice-president of quality and regulatory affairs at Allergy Laboratories and co-chair of the program planning committee for the 2013 PDA/FDA Joint Regulatory Conference, discusses quality systems and related considerations in parenteral drug manufacturing.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
3
High-Dose Nusinersen Slows Neurodegeneration in SMA Patients, Study Shows
4
Cellares Extends Cell Therapy Automation Beyond T Cell Therapies
5